Brief: Freeline Initiates Dosing Of Second Cohort In B-Lieve Dose Confirmation Trial Of FLT180A In Hemophilia B

Freeline Therapeutics Holdings

14/06/2022 12:30

June 14 (Reuters) - Freeline Therapeutics Holdings PLC
 FRLN.O :
    * FREELINE INITIATES DOSING OF SECOND COHORT IN B-LIEVE DOSE
CONFIRMATION TRIAL OF FLT180A IN HEMOPHILIA B
    * FREELINE THERAPEUTICS HOLDINGS PLC - COHORT ONE EFFICACY
AND
SAFETY DATA TO BE PRESENTED AT ISTH CONGRESS IN JULY
    * FREELINE THERAPEUTICS HOLDINGS PLC - START-UP ACTIVITIES
FOR
PIVOTAL PHASE 3 TRIAL ON TRACK TO BEGIN IN H1 2023

Source text for Eikon:  ID:nGNX6yMNbC 
Further company coverage:  FRLN.O